Resultaträkning Pfizer, Inc.

Aktier

PFE

US7170811035

Farmaceutiska produkter

Marknaden stängd - Nyse Andra börsplatser 22:00:02 17.01.2025			5-dagars förändring	Förändring 1 jan.
26,30 ^USD	−0,72 %		−1,57 %	−0,87 %

17.01.	Novo Nordisks Ozempic och Wegovy bland de läkemedel som valts ut för prissamtal med amerikanska Medicare	MT
17.01.	Novo Nordisks Ozempic och Wegovy bland de läkemedel som valts ut för prissamtal med amerikanska Medicare	MT

2c387245d30c7.TKYKjBEKAPhDZXTWwpy-Z-Vnqq61VcllGBXEDcIJa00.OvJz5mM5c8k3CECxtKzdEL8m5Zf2O4YyW1SqT69ZIHob82KhflJlmnYOLQ

Publicerade finansiella data: PFIZER, INC.

Årlig

Kvartalsvis

Halvårsvis

YTD

LTM

Skatteperiod: December	2019	2020	2021	2022	2023
Revenues	51,75 md	41,91 md	81,29 md	100 md	58,5 md
Total Revenues	51,75 md	41,91 md	81,29 md	100 md	58,5 md
Cost of Goods Sold, Total	10,01 md	8,57 md	30,66 md	34,1 md	23,99 md
Gross Profit	41,74 md	33,33 md	50,63 md	66,23 md	34,51 md
Selling General & Admin Expenses, Total	14,1 md	10,89 md	9,56 md	12,2 md	13,84 md
R&D Expenses	7,98 md	8,88 md	10,52 md	11,43 md	10,68 md
Amortization of Goodwill and Intangible Assets - (IS)	4,61 md	3,44 md	3,7 md	3,61 md	4,73 md
Other Operating Expenses, Total	26,7 md	23,2 md	23,78 md	27,24 md	29,25 md
Operating Income	15,04 md	10,13 md	26,84 md	39 md	5,26 md
Interest Expense, Total	−1,57 md	−1,45 md	−1,29 md	−1,24 md	−2,21 md
Interest And Investment Income	446 mn	351 mn	202 mn	565 mn	2,1 md
Net Interest Expenses	−1,13 md	−1,1 md	−1,09 md	−673 mn	−109 mn
Income (Loss) On Equity Invest.	17 mn	298 mn	471 mn	436 mn	505 mn
Currency Exchange Gains (Loss)	−172 mn	-	−192 mn	−1,15 md	164 mn
Other Non Operating Income (Expenses)	1,31 md	2,29 md	1,88 md	2,62 md	1,28 md
EBT, Excl. Unusual Items	15,07 md	11,62 md	27,92 md	40,22 md	7,09 md
Restructuring Charges	−1,28 md	−859 mn	−1,36 md	−2,02 md	−3,33 md
Merger & Related Restructuring Charges	−2 mn	−528 mn	-	−200 mn	−668 mn
Gain (Loss) On Sale Of Investments	8,54 md	546 mn	1,34 md	−1,27 md	1,59 md
Gain (Loss) On Sale Of Assets	31 mn	−237 mn	99 mn	-	222 mn
Asset Writedown	−2,84 md	−1,69 md	−86 mn	−421 mn	−3,02 md
In Process R&D Expenses	-	-	-	−953 mn	−194 mn
Insurance Settlements	50 mn	-	-	-	-
Legal Settlements	−472 mn	−28 mn	−182 mn	−230 mn	−474 mn
Other Unusual Items	−1,42 md	−1,32 md	−3,42 md	−394 mn	−157 mn
EBT, Incl. Unusual Items	17,68 md	7,5 md	24,31 md	34,73 md	1,06 md
Income Tax Expense	1,38 md	477 mn	1,85 md	3,33 md	−1,12 md
Earnings From Continuing Operations	16,3 md	7,02 md	22,46 md	31,4 md	2,17 md
Earnings Of Discontinued Operations	4 mn	2,63 md	−434 mn	6 mn	−15 mn
Net Income to Company	16,3 md	9,65 md	22,02 md	31,41 md	2,16 md
Minority Interest	−29 mn	−36 mn	−45 mn	−35 mn	−39 mn
Net Income - (IS)	16,27 md	9,62 md	21,98 md	31,37 md	2,12 md
Preferred Dividend and Other Adjustments	1 mn	-	-	-	-
Net Income to Common Incl Extra Items	16,27 md	9,62 md	21,98 md	31,37 md	2,12 md
Net Income to Common Excl. Extra Items	16,27 md	6,98 md	22,41 md	31,37 md	2,13 md
Per aktie poster
Net EPS - Basic	2,92	1,73	3,92	5,59	0,38
Basic EPS - Continuing Operations	2,92	1,26	4	5,59	0,38
Basic Weighted Average Shares Outstanding	5,57 md	5,56 md	5,6 md	5,61 md	5,64 md
Net EPS - Diluted	2,87	1,71	3,85	5,47	0,37
Diluted EPS - Continuing Operations	2,87	1,24	3,93	5,47	0,37
Diluted Weighted Average Shares Outstanding	5,68 md	5,63 md	5,71 md	5,73 md	5,71 md
Normalized Basic EPS	1,69	1,3	3,11	4,48	0,78
Normalized Diluted EPS	1,65	1,28	3,05	4,38	0,77
Dividend Per Share	1,44	1,52	1,56	1,6	1,64
Payout Ratio	49,43	87,77	39,72	28,63	436,38
American Depositary Receipts Ratio (ADR)	0,25	0,25	0,25	0,25	0,25
Kompletterande punkter
EBITDA	21,01 md	14,89 md	31,95 md	44,02 md	11,52 md
EBITA	19,65 md	13,56 md	30,54 md	42,6 md	9,99 md
EBIT	15,04 md	10,13 md	26,84 md	39 md	5,26 md
EBITDAR	21,71 md	15,66 md	32,84 md	45,24 md	12,8 md
Total Revenues (As Reported)	-	-	-	-	58,5 md
Effective Tax Rate - (Ratio)	7,83	6,36	7,62	9,58	−105,39
Current Domestic Taxes	−1,94 md	429 mn	3,38 md	2,72 md	1,19 md
Current Foreign Taxes	2,9 md	1,52 md	2,77 md	4,37 md	1,14 md
Total Current Taxes	958 mn	1,95 md	6,14 md	7,09 md	2,33 md
Deferred Domestic Taxes	1,35 md	−1,18 md	−4,34 md	−3,58 md	−2,79 md
Deferred Foreign Taxes	−919 mn	−292 mn	48 mn	−183 mn	−652 mn
Total Deferred Taxes	427 mn	−1,47 md	−4,29 md	−3,76 md	−3,44 md
Normalized Net Income	9,39 md	7,23 md	17,4 md	25,11 md	4,39 md
Interest Capitalized	88 mn	96 mn	108 mn	124 mn	160 mn
Non-Cash Pension Expense	206 mn	−76 mn	−2,14 md	−247 mn	−508 mn
Kompletterande driftskostnadsposter
Advertising Expense	2,6 md	1,8 md	2 md	2,8 md	3,7 md
Selling and Marketing Expenses	2,6 md	1,8 md	2 md	2,8 md	3,7 md
Research And Development Expense From Footnotes	8,65 md	9,4 md	13,83 md	11,43 md	10,68 md
Net Rental Expense, Total	700 mn	773 mn	888 mn	1,22 md	1,28 md
Imputed Operating Lease Interest Expense	195 mn	202 mn	240 mn	329 mn	424 mn
Imputed Operating Lease Depreciation	505 mn	571 mn	648 mn	889 mn	859 mn
Stock-Based Comp., Other (Total)	738 mn	776 mn	1,2 md	891 mn	545 mn
Total Stock-Based Compensation	738 mn	776 mn	1,2 md	891 mn	545 mn

Skatteperiod: December	2019	2020	2021	2022	2023
TILLGÅNGAR
Cash And Equivalents	1,3 md	1,78 md	1,94 md	416 mn	2,85 md
Short Term Investments	8,52 md	10,44 md	29,12 md	22,32 md	9,84 md
Trading Asset Securities, Total	53 mn	18 mn	4 mn	-	-
Total Cash And Short Term Investments	9,88 md	12,24 md	31,07 md	22,73 md	12,69 md
Accounts Receivable, Total	8,72 md	7,93 md	11,48 md	10,95 md	11,18 md
Other Receivables	3,34 md	3,26 md	4,27 md	3,58 md	3,98 md
Total Receivables	12,07 md	11,19 md	15,74 md	14,53 md	15,16 md
Inventory	8,28 md	8,05 md	9,06 md	8,98 md	10,19 md
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	2,57 md	3,59 md	3,82 md	5,02 md	5,3 md
Total Current Assets	32,8 md	35,07 md	59,69 md	51,26 md	43,33 md
Gross Property Plant And Equipment	32,07 md	30,1 md	32,8 md	34,45 md	37,91 md
Accumulated Depreciation	−16,79 md	−14,81 md	−15,07 md	−15,17 md	−16,04 md
Net Property Plant And Equipment	15,28 md	15,29 md	17,72 md	19,28 md	21,86 md
Long-term Investments	20,41 md	20,38 md	21,54 md	14,93 md	15,38 md
Goodwill	58,65 md	49,58 md	49,21 md	51,38 md	67,78 md
Other Intangibles, Total	35,37 md	28,47 md	25,15 md	43,37 md	64,9 md
Deferred Tax Assets Long-Term	900 mn	900 mn	1,6 md	4,8 md	1,8 md
Other Long-Term Assets, Total	4,07 md	4,54 md	6,57 md	12,2 md	11,44 md
Total Assets	167 md	154 md	181 md	197 md	227 md
Skulder
Accounts Payable, Total	4,22 md	4,31 md	5,58 md	6,81 md	6,71 md
Accrued Expenses, Total	6,59 md	6,51 md	7,67 md	8,32 md	9,22 md
Short-term Borrowings	14,73 md	701 mn	605 mn	385 mn	8,1 md
Current Portion of Long-Term Debt	1,46 md	2 md	1,64 md	2,57 md	2,27 md
Current Portion of Leases	276 mn	321 mn	449 mn	620 mn	527 mn
Current Income Taxes Payable	980 mn	1,05 md	1,27 md	1,59 md	2,35 md
Unearned Revenue Current, Total	9 mn	957 mn	4,02 md	2,52 md	2,7 md
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	9,04 md	10,07 md	21,44 md	19,33 md	15,92 md
Total Current Liabilities	37,3 md	25,92 md	42,67 md	42,14 md	47,79 md
Long-Term Debt	35,96 md	37,13 md	36,2 md	33,2 md	61,81 md
Long-Term Leases	1,05 md	1,11 md	2,51 md	2,6 md	2,63 md
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	6,76 md	5,41 md	3,72 md	2,25 md	2,17 md
Deferred Tax Liability Non Current	5,58 md	4,06 md	349 mn	1,02 md	640 mn
Other Non Current Liabilities	17,4 md	17,12 md	18,56 md	20,08 md	22,17 md
Total Liabilities	104 md	90,76 md	104 md	101 md	137 md
Preferred Stock Convertible	17 mn	-	-	-	-
Total Preferred Equity	17 mn	-	-	-	-
Common Stock, Total	468 mn	470 mn	473 mn	476 mn	478 mn
Additional Paid In Capital	87,43 md	88,67 md	90,59 md	91,8 md	92,63 md
Retained Earnings	97,67 md	96,77 md	103 md	126 md	118 md
Treasury Stock	−111 md	−111 md	−111 md	−114 md	−114 md
Comprehensive Income and Other	−11,64 md	−11,69 md	−5,9 md	−8,3 md	−7,96 md
Total Common Equity	63,13 md	63,24 md	77,2 md	95,66 md	89,01 md
Minority Interest	303 mn	235 mn	262 mn	256 mn	274 mn
Total Equity	63,45 md	63,47 md	77,46 md	95,92 md	89,29 md
Total Liabilities And Equity	167 md	154 md	181 md	197 md	227 md
Kompletterande objekt
ECS Total Shares Outstanding on Filing Date	5,55 md	5,58 md	5,62 md	5,62 md	5,65 md
ECS Total Common Shares Outstanding	5,53 md	5,57 md	5,62 md	5,62 md	5,65 md
Book Value / Share	11,41	11,36	13,74	17,03	15,77
Tangible Book Value	−30,9 md	−14,81 md	2,85 md	916 mn	−43,67 md
Tangible Book Value Per Share	−5,58	−2,66	0,51	0,16	−7,73
Total Debt	53,47 md	41,27 md	41,4 md	39,38 md	75,33 md
Net Debt	43,59 md	29,03 md	10,32 md	16,64 md	62,64 md
Debt Equivalent of Unfunded Proj. Benefit Obligation	5,4 md	4,4 md	1,73 md	1,18 md	561 mn
Debt Equivalent Oper. Leases	5,6 md	6,18 md	7,1 md	9,74 md	10,26 md
Minority Interest, Total (Incl. Fin. Div)	303 mn	235 mn	262 mn	256 mn	274 mn
Equity Method Investments, Total	17,13 md	16,86 md	16,47 md	11,03 md	11,64 md
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	790 mn	738 mn	994 mn	859 mn	1,01 md
Inventories - Work In Process, Total	4,74 md	4,43 md	4,42 md	5,52 md	5,69 md
Inventories - Finished Goods, Total	2,75 md	2,88 md	3,64 md	2,6 md	3,5 md
Land - (BS)	516 mn	444 mn	423 mn	368 mn	353 mn
Buildings, Total	10,07 md	9,02 md	9 md	8,83 md	9,05 md
Machinery, Total	17,21 md	15,69 md	16,71 md	17,37 md	19,66 md
Full Time Employees	88,3 tn	78,5 tn	79 tn	83 tn	88 tn
Accumulated Allowance for Doubtful Accounts (Supple)	527 mn	508 mn	492 mn	449 mn	470 mn

Skatteperiod: December	2019	2020	2021	2022	2023
Net Income	16,27 md	9,62 md	21,98 md	31,37 md	2,12 md
Depreciation & Amortization - CF	1,36 md	1,32 md	1,4 md	1,42 md	1,52 md
Amortization of Goodwill and Intangible Assets - (CF)	4,61 md	3,44 md	3,7 md	3,61 md	4,73 md
Depreciation & Amortization, Total	5,97 md	4,76 md	5,1 md	5,03 md	6,26 md
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	−8,23 md	−6 mn	-	-	-
Asset Writedown & Restructuring Costs	2,99 md	2,07 md	363 mn	586 mn	3,44 md
Stock-Based Compensation (CF)	718 mn	756 mn	1,18 md	872 mn	525 mn
Net Cash From Discontinued Operations	-	3,82 md	−343 mn	-	15 mn
Other Operating Activities, Total	−1,1 md	−6,33 md	−8,51 md	−4,14 md	−1,48 md
Change In Accounts Receivable	−742 mn	−1,25 md	−3,81 md	261 mn	347 mn
Change In Inventories	−1,05 md	−736 mn	−1,12 md	592 mn	−1,17 md
Change In Accounts Payable	−564 mn	353 mn	1,24 md	1,19 md	−300 mn
Change in Other Net Operating Assets	−1,68 md	1,36 md	16,5 md	−6,5 md	−1,05 md
Cash from Operations	12,59 md	14,4 md	32,58 md	29,27 md	8,7 md
Capital Expenditure	−2,18 md	−2,25 md	−2,71 md	−3,24 md	−3,91 md
Cash Acquisitions	−10,86 md	-	-	−23 md	−43,43 md
Sale (Purchase) of Intangible assets	−418 mn	−539 mn	-	-	-
Investment in Marketable and Equity Securities, Total	9,3 md	−1,67 md	−19,52 md	6,68 md	15,24 md
Other Investing Activities, Total	206 mn	192 mn	−318 mn	3,77 md	−180 mn
Cash from Investing	−3,94 md	−4,27 md	−22,55 md	−15,78 md	−32,28 md
Short Term Debt Issued, Total	19,01 md	12,35 md	-	3,89 md	7,69 md
Long-Term Debt Issued, Total	4,94 md	5,22 md	997 mn	-	30,83 md
Total Debt Issued	23,95 md	17,57 md	997 mn	3,89 md	38,52 md
Short Term Debt Repaid, Total	−8,38 md	−26,33 md	−96 mn	−4,11 md	−3 mn
Long-Term Debt Repaid, Total	−6,81 md	−4 md	−2 md	−3,3 md	−2,57 md
Total Debt Repaid	−15,18 md	−30,33 md	−2,1 md	−7,41 md	−2,57 md
Issuance of Common Stock	394 mn	425 mn	-	-	-
Repurchase of Common Stock	−8,86 md	-	-	−2 md	-
Common Dividends Paid	-	−8,44 md	−8,73 md	−8,98 md	−9,25 md
Common & Preferred Stock Dividends Paid	−8,04 md	-	-	-	-
Common & Preferred Stock Dividends Paid	−8,04 md	−8,44 md	−8,73 md	−8,98 md	−9,25 md
Other Financing Activities, Total	−735 mn	11,12 md	16 mn	−335 mn	−632 mn
Cash from Financing	−8,48 md	−9,65 md	−9,82 md	−14,83 md	26,07 md
Foreign Exchange Rate Adjustments	−32 mn	−8 mn	−59 mn	−165 mn	−40 mn
Miscellaneous Cash Flow Adjustments	−1 mn	-	-	-	-
Net Change in Cash	125 mn	475 mn	159 mn	−1,52 md	2,45 md
Kompletterande punkter
Cash Interest Paid	1,59 md	1,64 md	1,47 md	1,44 md	2,22 md
Cash Income Tax Paid (Refund)	3,66 md	3,15 md	7,43 md	7,87 md	3,15 md
Levered Free Cash Flow	18,42 md	10,5 md	30,86 md	24,96 md	1,02 md
Unlevered Free Cash Flow	19,4 md	11,41 md	31,66 md	25,73 md	2,4 md
Change In Net Working Capital	−5,89 md	−2,33 md	−11,29 md	1,32 md	3,78 md
Net Debt Issued / Repaid	8,76 md	−12,76 md	−1,1 md	−3,52 md	35,94 md

Skatteperiod: December	2019	2020	2021	2022	2023
Lönsamhet
Return on Assets	5,75	3,93	10	12,87	1,55
Return on Total Capital	8,44	5,71	15,01	19,18	2,19
Return On Equity %	25,62	11,06	31,87	36,22	2,35
Return on Common Equity	25,72	11,06	31,92	36,29	2,31
Marginalanalys
Gross Profit Margin %	80,66	79,54	62,28	66,02	58,99
SG&A Margin	27,25	25,99	11,77	12,16	23,65
EBITDA Margin %	40,61	35,52	39,3	43,88	19,69
EBITA Margin %	37,97	32,37	37,58	42,46	17,08
EBIT Margin %	29,07	24,17	33,02	38,87	8,99
Income From Continuing Operations Margin %	31,49	16,75	27,63	31,3	3,71
Net Income Margin %	31,45	22,95	27,04	31,27	3,62
Net Avail. For Common Margin %	31,44	16,67	27,57	31,26	3,65
Normalized Net Income Margin	18,15	17,24	21,41	25,02	7,51
Levered Free Cash Flow Margin	35,6	25,05	37,96	24,87	1,75
Unlevered Free Cash Flow Margin	37,5	27,22	38,95	25,65	4,11
Tillgångsomslutning